We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Supply Agreement for Microbiologic System

By Biotechdaily staff writers
Posted on 09 Jan 2006
A purchase-and-supply agreement has been announced by Thermo Electron Corp. More...
(Milford, MA, USA), whereby the company will supply customized incubation platforms for integration with the automated rapid microbiologic detection system of Genomic Profiling Systems (Bedford, MA, USA) for pharmaceutical manufacturing.

Thermo's Cytomat 6001 incubation platform will provide automated culture-plate incubation to complete the integrated Growth Direct System of Genomic Profiling, which significantly reduces incubation time, the most important limitation of traditional culture-based tests used in the microbiologic testing of pharmaceuticals. The Cytomat 6001 provides an incubation environment with a single access point that can easily be configured to integrate with any automated assay system.

"Thermo was an obvious contender with its broad product offering and proven Cytomat incubators,” noted Bob Linke, president and CEO of Genomic Profiling Systems. "What really made the difference was Thermo's ability to quickly customize the platform to our specification.”

Genomic Profiling's Growth Direct System uses digital imaging to accelerate testing. The system enumerates organisms grown in culture days to weeks earlier than feasible by the human eye. A non-destructive system, it permits retention of organisms for required identification, differentiating it from available rapid microbiology systems.

"We anticipate that the Growth Direct System will dramatically reduce the cost of pharmaceutical microbiology by decreasing wait times by at least 50% and by automating labor-intensive methods,” added Bob Linke.




Related Links:
Thermo Electron
Genomic Profiling Systems

Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
New
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
New
All-in-One Molecular System
AIO M160
New
Repetitive Pipette
VWR® Stepper Pro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.